Ligand Pharmaceuticals has acquired a Roche-partnered program from Icagen. The deal comes a little more than one year after Roche and Icagen entered into a drug discovery pact aimed at neurological disorders.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,